Addiction

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA

MIAMI, FL / ACCESSWIRE / September 11, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing...

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

CHATHAM, NJ / ACCESSWIRE / September 4, 2024 / This post was written and published as a collaboration between the...

Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed New Director of Institute for Genome Sciences

Internationally-recognized for her work in developing predictive models for drug resistance in cancer treatment BALTIMORE, Aug. 30, 2024 /PRNewswire/ --...

RELEASE RECOVERY ACQUIRES LEADING MEN’S PERSONAL WELLBEING PLATFORM MANUAL TO EXPAND NATIONAL REACH AND OFFER MORE COMPREHENSIVE SERVICES

New Entity Combines Release Recovery's Best in Class Behavioral Health Care Services to Include MANUAL's Technology Platform and College Campus...

Compassion Center and CIFR Honored to Present at the VA/DOD Suicide Prevention Conference 2024, Increasing the Reach and Improving Outcomes for Veterans and Active Duty Military

error: Content is protected !!